Huashan Hospital of Fudan University – MatriDx Molecular diagnostic laboratory launched

/in /by

On Feb, 2020, China’s first NextSeq?550Dx was successfully installed and started up, it means Huashan Hospital of Fudan University - MatriDx Molecular diagnostic laboratory is lanched.

Huashan Hospital of Fudan University -MatriDx Molecular Diagnostic Laboratory is a Clinical scientific research laboratory which jointly led by Institute of Antibiotics of Huashan Hospital of Fudan University(State Key Laboratory) and Hangzhou MatriDx Biotechnology Co Ltd.

Read more

MatriDx has signed a agreement with GoBroad Healthcare Group, to create a new situation of precision diagnosis and treatments on oncology.

/in /by

Recently, Hangzhou Matridx biotechnology Co Ltd has signed a agreement with Go Broad Healthcare Group in Beijing Boren Hospital.

Dr. Wang Jun, founder and CEO of MatriDx, Mr. Zhang Jiecheng, general manager of GoBroad Healthcare Group, and the main leaders of both parties attended the signing ceremony. Based on this cooperation, the two parties will build the microbial mNGS technology platform, and promote microbial mNGS technology to a wider application, make precision diagnosis and treatment technology benefit the patients

Read more

Infection Precision Diagnosis and Treatment Summit Forum was successfully held!

/in /by

In 30th, Jar, 2021, Infection Precision Diagnosis and Treatment Summit Forum was successfully held by MatriDx and in the same day, MatriDx official launched MatriDx Clinical Laboratory in Hangzhou.

Read more